ES430759A1 - Procedimiento para preparar derivados de isoquinolina. - Google Patents

Procedimiento para preparar derivados de isoquinolina.

Info

Publication number
ES430759A1
ES430759A1 ES430759A ES430759A ES430759A1 ES 430759 A1 ES430759 A1 ES 430759A1 ES 430759 A ES430759 A ES 430759A ES 430759 A ES430759 A ES 430759A ES 430759 A1 ES430759 A1 ES 430759A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
alkoxy
formula
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES430759A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES430759A1 publication Critical patent/ES430759A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
ES430759A 1973-10-08 1974-10-07 Procedimiento para preparar derivados de isoquinolina. Expired ES430759A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (zh) 1973-10-08 1973-10-08

Publications (1)

Publication Number Publication Date
ES430759A1 true ES430759A1 (es) 1977-04-16

Family

ID=4399720

Family Applications (1)

Application Number Title Priority Date Filing Date
ES430759A Expired ES430759A1 (es) 1973-10-08 1974-10-07 Procedimiento para preparar derivados de isoquinolina.

Country Status (21)

Country Link
JP (1) JPS5082078A (zh)
AT (1) ATA802974A (zh)
AU (2) AU498889B2 (zh)
BE (1) BE820789A (zh)
CA (1) CA1021772A (zh)
CH (1) CH581113A5 (zh)
DD (1) DD114605A5 (zh)
DE (1) DE2447756A1 (zh)
DK (1) DK135766B (zh)
ES (1) ES430759A1 (zh)
FI (1) FI286374A (zh)
FR (1) FR2247242B1 (zh)
GB (1) GB1474775A (zh)
HU (1) HU169126B (zh)
IL (1) IL45797A (zh)
NL (1) NL7413105A (zh)
NO (1) NO743534L (zh)
PH (1) PH11611A (zh)
SE (1) SE7412310L (zh)
SU (1) SU567403A3 (zh)
ZA (1) ZA746409B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI760704A (zh) * 1975-03-26 1976-09-27 Sandoz Ag
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
SE7804318L (sv) * 1977-05-02 1978-11-03 Merck & Co Inc Nya naftyridiner
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
AU2001275085A1 (en) 2000-06-01 2001-12-11 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
GB1474775A (en) 1977-05-25
ZA746409B (en) 1976-05-26
CH581113A5 (zh) 1976-10-29
ATA802974A (de) 1979-07-15
NO743534L (zh) 1975-05-05
NL7413105A (nl) 1975-04-10
DE2447756A1 (de) 1975-04-10
AU7408974A (en) 1976-04-15
CA1021772A (en) 1977-11-29
IL45797A (en) 1978-04-30
DD114605A5 (zh) 1975-08-12
DK135766C (zh) 1977-11-21
PH11611A (en) 1978-04-12
AU7409074A (en) 1976-04-15
AU7413074A (en) 1976-04-15
SU567403A3 (ru) 1977-07-30
IL45797A0 (en) 1974-12-31
HU169126B (zh) 1976-09-28
DK514874A (zh) 1975-06-09
AU498889B2 (en) 1979-03-29
SE7412310L (zh) 1975-04-09
DK135766B (da) 1977-06-20
FR2247242B1 (zh) 1978-07-21
BE820789A (fr) 1975-04-07
FR2247242A1 (zh) 1975-05-09
JPS5082078A (zh) 1975-07-03
FI286374A (zh) 1975-04-09

Similar Documents

Publication Publication Date Title
ES430759A1 (es) Procedimiento para preparar derivados de isoquinolina.
NO168705C (no) 3-nitro-kinoliner.
ES450740A1 (es) Procedimiento para preparar derivados de vincamina.
ES436665A1 (es) Un procedimiento de preparacion de derivados de 3-(tiazol-2-oxi)-propanol.
ES401710A1 (es) Procedimiento para la preparacion de nuevos compuestos bi- ciclicos nitrogenados.
ES421068A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES409104A1 (es) Procedimiento para la obtencion de derivados de 7-amino-indazol.
ES419019A1 (es) Procedimiento para la preparacion de compuestos polici- clicos.
ES443421A1 (es) Un procedimiento para la preparacion de una composicion far-macologica que contiene una 11-desoxi-gamma-pentanorprosta- glandina.
ES412047A1 (es) Un procedimiento para la preparacion de dihidrocumarina o una alcohil-dihidrocumarina.
ES373149A1 (es) Procedimiento para producir nuevos derivados de benzodiaze-pina.
ES363129A1 (es) Un procedimiento para la preparacion de un compuesto de te-trahidroisoquinoleina.
ES478656A1 (es) Procedimiento para preparar derivados de isoindolina.
GB1174365A (en) Benzotriazole Derivatives
GB1499193A (en) Indolino-spiropyran compounds useful as colour formers
ES446565A1 (es) Un procedimiento para la preparacion de derivados de 1, 1- difenil-2-hidroxi-3-aminopropano.
ES472572A1 (es) Un procedimiento para la preparacion de derivados de morfi- nano 3-fenoxi-n-sustituidos levogiros
ES379157A1 (es) Procedimiento para la obtencion de derivados de la quinazo-lina.
ES451291A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES445255A1 (es) Un procedimiento para la preparacion de acidos metil-2 o 3- cefem-4-carboxilicos 3-sustituidos.
ES367957A1 (es) Un procedimiento para la preparacion de derivados de benzo-diacepina.
ES385679A1 (es) Un procedimiento para la preparacion de derivados de n-ari-lideno de compuestos de eritromicilamina.
ES455650A1 (es) Procedimiento para preparar colorates monoazoicos dispersa- dos.
ES468278A1 (es) Un procedimiento de preparacion de nuevos derivados de la tienopiridina.
ES457895A1 (es) Metodo para preparar derivados de tirosina.